Literature DB >> 24184385

Dynorphins regulate the strength of social memory.

A Bilkei-Gorzo1, D Mauer2, K Michel2, A Zimmer2.   

Abstract

Emotionally arousing events like encounter with an unfamiliar con-species produce strong and vivid memories, whereby the hippocampus and amygdala play a crucial role. It is less understood, however, which neurotransmitter systems regulate the strength of social memories, which have a strong emotional component. It was shown previously that dynorphin signalling is involved in the formation and extinction of fear memories, therefore we asked if it influences social memories as well. Mice with a genetic deletion of the prodynorphin gene Pdyn (Pdyn(-/-)) showed a superior partner recognition ability, whereas their performance in the object recognition test was identical as in wild-type mice. Pharmacological blockade of kappa opioid receptors (KORs) led to an enhanced social memory in wild-type animals, whereas activation of KORs reduced the recognition ability of Pdyn(-/-) mice. Partner recognition test situation induced higher elevation in dynorphin A levels in the central and basolateral amygdala as well as in the hippocampus, and also higher dynorphin B levels in the hippocampus than the object recognition test situation. Our result suggests that dynorphin system activity is increased in emotionally arousing situation and it decreases the formation of social memories. Thus, dynorphin signalling is involved in the formation of social memories by diminishing the emotional component of the experience.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dynorphin immunoreactivity; NorBNI; Object recognition; Social recognition; U-50488

Mesh:

Substances:

Year:  2013        PMID: 24184385     DOI: 10.1016/j.neuropharm.2013.10.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons.

Authors:  Önder Albayram; Stefan Passlick; Andras Bilkei-Gorzo; Andreas Zimmer; Christian Steinhäuser
Journal:  Pflugers Arch       Date:  2016-01-07       Impact factor: 3.657

2.  Adolescent forced swim stress increases social anxiety-like behaviors and alters kappa opioid receptor function in the basolateral amygdala of male rats.

Authors:  E I Varlinskaya; J M Johnson; K R Przybysz; T Deak; M R Diaz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-11-07       Impact factor: 5.067

3.  Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.

Authors:  An-Li Wang; Steven B Lowen; Igor Elman; Zhenhao Shi; Victoria P Fairchild; Alexander Bouril; Ruben C Gur; Daniel D Langleben
Journal:  J Subst Abuse Treat       Date:  2017-10-18

Review 4.  Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.

Authors:  Nicole A Crowley; Thomas L Kash
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-12       Impact factor: 5.067

5.  Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.

Authors:  L Lalanne; G Ayranci; D Filliol; C Gavériaux-Ruff; K Befort; B L Kieffer; P-E Lutz
Journal:  Addict Biol       Date:  2016-03-22       Impact factor: 4.280

Review 6.  Neuromodulatory signaling in hippocampus-dependent memory retrieval.

Authors:  Steven A Thomas
Journal:  Hippocampus       Date:  2015-04       Impact factor: 3.753

7.  A functional polymorphism in the prodynorphin gene affects cognitive flexibility and brain activation during reversal learning.

Authors:  Mikhail Votinov; Juergen Pripfl; Christian Windischberger; Ewald Moser; Uta Sailer; Claus Lamm
Journal:  Front Behav Neurosci       Date:  2015-07-03       Impact factor: 3.558

Review 8.  Kappa Opioids, Salvinorin A and Major Depressive Disorder.

Authors:  George T Taylor; Francesca Manzella
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.

Authors:  Aline Hajj; Lucine Halepian; Nada El Osta; Georges Chahine; Joseph Kattan; Lydia Rabbaa Khabbaz
Journal:  Int J Mol Sci       Date:  2017-03-27       Impact factor: 5.923

10.  Integrated identification of key genes and pathways in Alzheimer's disease via comprehensive bioinformatical analyses.

Authors:  Tingting Yan; Feng Ding; Yan Zhao
Journal:  Hereditas       Date:  2019-07-16       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.